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Abstract:  Introduction: Over 500,000 total knee arthroplasties (TKAs) are performed annually in the US, yet 
postoperative pain management varies widely. In patients managed with epidural analgesia, the epidural catheter is 
generally removed on the second postoperative day. We compared in-hospital outcomes associated with removing the 
epidural catheter on postoperative day 1 (POD1-group) vs on postoperative day 2 (POD2-group) among patients 
undergoing TKA. 
Methods: We identified 89 patients who had TKA performed by a single surgeon from January through July 2007, and 
who were managed with epidural analgesia. This study took advantage of a change of policy from removing the epidural 
on the second postoperative day prior to March 2007 (n = 34) to removing the epidural on the first postoperative day 
thereafter (n = 55). Data were obtained by medical record review and analyzed with bivariate and multivariate techniques. 
Outcomes included knee range of motion (ROM), pain (0-10 scale), distance walked, narcotic usage, and length of stay. 
Results: The mean patient age was 68 ± 10 years. We did not identify clinically important differences in preoperative 
characteristics across groups. Patients in the POD1- group had a shorter length of stay (median of 3 vs 4 days in the 
POD2-group, p<0.001). The POD1-group also walked a greater distance on the second postoperative day (mean of 38 feet 
vs 9 feet in the POD2-group, p < 0.002). We did not observe a difference between the two groups with respect to change 
in passive ROM, pain on the second postoperative day, or narcotic usage. The POD1-group  had more restricted 
continuous passive motion settings on the second postoperative day than the POD2-group (50° vs  65°, p = 0.031), and the 
POD1-group had somewhat worse passive range of motion at discharge (e.g. passive flexion 82
o vs  76
o in the POD2-
group, p = 0.078). 
Conclusion: The balance between a shorter hospital stay and earlier walking achievement with the POD1-strategy-- vs 
better ROM at the time of discharge with the POD2-strategy-- should be considered when planning TKA pain 
management. These results should be confirmed with longer term studies and randomized designs. 
Evidence Level III: Retrospective comparative study. 
Keywords: Knee, arthroplasty, analgesia. 
INTRODUCTION 
  More than 500,000 total knee arthroplasty (TKA) 
procedures are performed annually in the United States [1]. 
Between 1990 and 2002, the number of TKAs almost tripled 
[2]. By 2030, the demand for TKA is estimated to increase to 
3.5 million procedures annually [1]. Recovering from TKA is 
painful for patients and postoperative pain impedes early 
physical therapy [3]. Hence, postoperative pain management is 
a key priority. Despite the large volume of TKAs performed, 
postoperative pain management strategies vary substantially. 
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  Patients undergoing TKA receive either general or 
regional anesthesia. Postoperative pain management options 
include intravenous patient-controlled analgesia (PCA), 
epidural infusion, and parenteral and oral opioids. One meta-
analysis compared neuraxial (spinal or epidural) blockades to 
general anesthesia across various surgical specialties and 
noted an overall mortality reduction by a third among 
patients receiving neuraxial anesthesia [4]. In addition, 
patients receiving neuraxial anesthesia have been reported to 
experience fewer serious postoperative complications than 
patients receiving general anesthesia, including cardiac 
morbidity (30% fewer complications), pulmonary infections 
(40% fewer), pulmonary embolism (50%), acute renal failure 
(30%), and blood loss (30%) [4, 5]. Neuraxial and 
peripherally-delivered analgesia following TKA reduce the 
endocrine stress response, provide superior postoperative 32    The Open Orthopaedics Journal, 2010, Volume 4  Corbett et al. 
pain relief and improve joint mobility when compared to 
parenteral opioids [3, 6-8]. A key advantage of epidural 
anesthesia is that the catheter can be used to administer both 
intraoperative anesthesia and postoperative analgesia. 
Epidural anesthesia and analgesia have been shown to 
promote early rehabilitation, reduce the length of hospital 
stay, and decrease the risk of deep vein thrombosis after total 
joint arthroplasty [9-11]. As a result, epidural anesthesia and 
analgesia are frequently used pain management strategies for 
TKA. 
  The optimal duration of postoperative epidural analgesia 
has not been clarified. Traditionally, the epidural catheter is 
removed after 48 hours; longer duration increases the risk of 
spinal hematoma associated with perioperative anticoagulation 
[12-15]. However, stopping the epidural infusion on 
postoperative day two may prolong inactivity resulting in 
delayed rehabilitation. We hypothesized that by removing 
the epidural catheter on postoperative day one, rehabilitation 
milestones, including ambulation, would be attained earlier 
and length of hospital stay would shorten while pain control 
would be comparable to the two-day analgesia strategy. To 
address these hypotheses, we took advantage of a change in 
clinical policy in one surgeon’s practice to compare the 
inpatient clinical and healthcare utilization outcomes of two 
groups of patients who underwent TKA. The first group had 
epidural catheters removed on postoperative day one (POD1-
group) and the second group had epidural catheters removed 
on postoperative day two (POD2-group). 
METHODS 
Design 
  We conducted a retrospective cohort study that took 
advantage of a change in practice policy in March 2007. 
Prior to this point, epidurals were removed on the second 
postoperative day. After March 2007, the policy was 
changed to remove the epidural on the first postoperative 
day. Prompted by the desire to control length of stay, and 
attributing patients’ poor postoperative day two experiences 
to the prolonged epidural, the change of practice was 
initiated to shorten epidural use to a single day. 
Study Sample 
  The study sample was composed of patients who 
underwent TKA performed by a single surgeon at a large 
orthopedic referral center in a metropolitan area. Ninety-six 
consecutive patients were identified from the surgeon’s 
schedule and their electronic medical records were reviewed. 
Seven patients were excluded because of inadequate 
documentation of outcomes in the patients’ medical record 
(3 patients), or because the patients’ epidural analgesia was 
stopped prematurely (4 patients). Thirty-four patients had the 
epidural removed on postoperative day two (POD2-group); 
these patients underwent TKA between January and 
February of 2007. By the summer months, the change to the 
epidural practice had been fully operationalized in the clinic. 
The POD2-group was compared to 55 patients with epidurals 
removed on postoperative day one (POD1-group); these 
procedures were performed between June and July of 2007. 
Institutional review board approval was obtained prior to 
conducting this study. 
 
Intervention 
  TKA was performed by a single surgeon using the PFC 
Sigma Cruciate Retaining cemented prosthesis, using a 
standard medial parapatellar tendon arthrotomy. The surgery 
was performed with a tourniquet and drains were not used. 
The anesthesiology service placed the epidural catheter just 
prior to surgery. The epidural anesthetic generally consisted 
of lidocaine and bupivicaine and often hydromorphone, with 
doses titrated to patient weight and tolerance. While the 
epidural anesthetic was not standardized, the same anesthesia 
service cared for both study groups in an identical manner 
with the exception of the shortened epidural duration. 
Postoperative pain control also did not change between 
groups. However, oxycontin was initiated before the epidural 
was removed in the POD1-group, which wasn’t necessarily 
true in the POD2-group. Patients received either 325 mg 
aspirin daily or coumadin with INR 1.8-2.3 for three weeks 
prostoperatively for DVT prophylaxis, with the treatment 
decision based on the patient’s BMI, history of 
thromboembolism, and other risk factors for DVT or PE. 
The physical therapy protocol involved initial evaluation on 
the first day after surgery. Patients were seen once daily by 
the physical therapist or physical therapist assistant for thirty 
to sixty-minute sessions. The therapist adhered to a protocol 
that emphasized regaining strength, knee flexion and 
extension range of motion, improving proprioception, 
increasing independence with transfers, and use of 
supportive walking devices for level ambulation and stairs. 
All patients were managed with a continuous passive motion 
machine for approximately six hours per day in two hour 
sessions starting the morning after surgery. 
Data Sources 
  We obtained preoperative and perioperative (within 
inpatient stay) data from surgical, nursing, and physical 
therapy notes in the medical records. Supplementary narcotic 
medication usage was collected from pharmacy records over 
the course of the patients’ hospital stay. 
Baseline Characteristics 
  Baseline characteristics included age, body mass index 
(BMI), gender, race (Caucasian or non-Caucasian), side of 
the operation, preoperative ambulation (independent or with 
walking aid), Charlson comorbidity index score (a validated, 
weighted sum of the number and severity of medical 
problems, scored in this analysis as 0-1 or  2) [16], 
preoperative living status (alone or not alone), preoperative 
primary diagnosis (osteoarthritis or other), smoking status, 
and insurance status. 
Outcomes 
  The primary outcome was length of stay (LOS), 
measured as the number of days from surgery to discharge. 
We also considered several patient-based secondary 
outcomes including pain, functional measures, discharge 
destination and supplemental narcotic usage. 
 Pain was assessed by physical therapists during daily 
activity and was measured on a 0-10 scale, 10 being the 
worst. For most patients, pain was measured once per day  
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over the course of the hospital stay. In cases where pain was 
measured more than once per day, we collected the highest 
(worst) level of pain recorded for that particular day. For this 
analysis, we compared the two groups’ pain levels on 
postoperative day two. 
 Functional  outcomes included distance walked on 
postoperative day two, measured in feet. We also analyzed 
degree of assistance needed for walking at time of discharge 
using the response format of the validated Functional 
Independence Measure (FIM) [17, 18]. This outcome was 
dichotomized as none or minimum vs moderate, maximum, 
or can’t perform. Passive range of motion (ROM) was 
measured using a goniometer. Passive knee flexion and 
extension data were collected on postoperative day one and 
at discharge. We also calculated the change in ROM from 
postoperative day one to discharge for each patient. 
Continuous passive motion (CPM) settings were compared 
at postoperative day two. 
  Supplementary narcotic medication usage was measured 
by converting the various opiate medication dosages into 
milligrams of oxycodone-equivalents. We used oxycodone-
equivalents because this drug was the most frequently used 
analgesic in this cohort. A table of narcotic conversion data 
(see Appendix) was developed and verified from a number 
of sources, including the American Pain Society and 
Thomson’s Healthcare DrugDex Consult database [19-22]. 
We compared the average cumulative usage of oxycodone-
equivalents on the day the epidural catheter was removed. 
We also compared use of oxycodone-equivalents between 
the groups on the day after the epidural was pulled 
(postoperative day two in the POD1-group and postoperative 
day three in the POD2-group). Patient-controlled analgesia 
(PCA) narcotics were not included in the calculation of 
cumulative narcotics dose, because the retrospective nature 
of the study precluded us from determining how much of the 
medication the patient had received. However, we did create 
an indicator variable distinguishing whether the patient 
received PCA and we controlled for this variable in our 
analysis. Narcotics dispensed through the epidural catheter 
were also excluded from this supplementary analysis 
because it was not possible to compare the quantity of 
analgesia between epidural administration and 
oral/parenteral narcotics. 
Analysis 
  Length of stay was compared between the two groups 
using the Wilcoxon rank-sum test. Pain scores, walking 
distance, and CPM settings at postoperative day two, as well 
as passive ROM at postoperative day one, passive ROM at 
discharge, and change in passive ROM between 
postoperative day one and discharge were compared between 
the groups using the independent samples t-test. Discharge 
destination and assistance level needed for walking at 
discharge were compared using the Chi-square test. 
  Since supplementary narcotic medication was ascertained 
at multiple time points, repeated measures ANOVA was 
used to examine the impact of epidural strategy controlling 
for time. For this analysis, time was the number of days 
since the catheter was removed. For example, Day 1 
represents the first 24 hours since the epidural catheter was 
removed. Day 2 represents the second 24 hours since the 
epidural catheter was removed. All of the above analyses 
were performed using SAS software, version 9.1. 
  Due to the modest sample size and the fact that LOS was 
not normally distributed, we analyzed LOS using techniques 
that do not require that the variable have a normal 
distribution. Specifically, we chose a robust regression 
analysis with fixed bootstrap re-sampling to determine the 
effect of epidural strategy on length of stay. This approach 
provides accurate estimates and valid 95% confidence 
intervals even if the assumptions of ordinary linear 
regression are not met, while maintaining the same 
interpretability as linear regression. The bootstrap procedure 
is essentially a series of regressions performed on subsets of 
the same population. In this case, it was performed using 
10,000 replicates. The parameter estimates and standard 
errors from these multiple bootstrap regression results were 
used to calculate adjusted means and 95% confidence 
intervals for the parameter of interest. We built a model that 
included an interaction term of epidural strategy and 
discharge destination because we hypothesized that the 
epidural strategy would have different effects on LOS in 
subjects discharged home than in subjects discharged to 
another inpatient facility. We also controlled for insurance 
status in this analysis, as this variable may affect discharge 
destination. This analysis was performed using R statistical 
software, version 2.6.2. [23] 
Sample Size 
  The primary outcome variable was LOS. Prior data from 
our center suggested the standard deviation in LOS was 
approximately 0.25 days. Thus, we sought to detect a 
difference in LOS between the 1-day and 2-day groups of at 
least 0.25 days. With Type I error of 0.05 and power of 90% 
this required 22 patients in each group. We included at least 
30 in each group to account for errors in these assumptions 
and to increase power for secondary outcomes. 
Source of Funding 
  The funding sources (Departmental Funds, NIH) played 
no role in the design or conduct of the study. 
RESULTS 
Cohort Characteristics 
  The mean age of the entire cohort was 68 ± 10 years and 
the mean BMI was 31 ± 7 kg/m
2. Seventy-eight percent were 
female, 84% were Caucasian, 29% percent had a Charlson 
comorbidity score  2, and 96% underwent TKA for 
osteoarthritis. Other baseline characteristics of the sample 
were similar between the two groups (Table 1) except for 
smoking status. In the POD1-group, 10% reported being a 
current smoker and 27% reported being a past smoker, while 
no study subjects reported being a current smoker and 55% 
reported being a past smoker in the POD2-group (p = 0.02). 
Bivariate Analyses 
Length of Stay 
  Results of the Wilcoxon rank-sum test found that the 
POD2-group had a statistically significantly greater length of 
stay than the POD1-group. The median length of stay for the 
POD2-group was 4 days (mean 4.0, range: 3-7 days), while 34    The Open Orthopaedics Journal, 2010, Volume 4  Corbett et al. 
the median length of stay for the POD1-group was 3 days 
(mean 3.2, range: 2-5 days; p < 0.001). 
Patient Outcomes 
  Results of the independent samples t-test found no 
differences between the groups with respect to pain scores at 
postoperative day two (p = 0.445). The POD2-group 
experienced better passive flexion at postoperative day one 
than the POD1-group (mean = 73° and 66° respectively; p = 
0.045). The POD2-group also experienced better passive 
flexion at discharge than the POD1-group (mean = 82° and 
76° respectively) although the difference was not statistically 
significant (p = 0.078). At the first postoperative day, the 
POD2-group experienced better passive extension than the 
POD1-group (mean = 6° and 10° lacking full extension 
respectively; p = 0.013). The POD2-group also experienced 
better passive extension at discharge than the POD1-group 
(mean = 4° and 7° lacking full extension respectively; 
p=0.047). There was no difference between the two groups 
for change in passive flexion (p = 0.665) or passive   
 
extension (p = 0.356) from the first postoperative day to 
discharge. The POD2-group had a higher mean CPM setting 
at postoperative day two than the POD1-group (mean = 65° 
and 50° respectively; p=0.031). The POD1-group walked a 
greater distance at the second postoperative day than the 
POD2-group (mean = 38 and 9 feet respectively, p < 0.002). 
Multivariable linear regression models of these outcomes 
(pain, range of motion, walking distance) did not alter the 
effect of epidural strategy on these outcomes when 
controlling for age, gender, and race. Thus, we have chosen 
to present just the bivariate analyses. 
  Results of the chi-square test found no difference 
between the two epidural strategies with respect to assistance 
level needed for walking at discharge and discharge 
destination (p = 0.703 and 0.738 respectively; Table 2). 
Multivariable logistic regression models did not alter the 
effect of epidural strategy on these outcomes when 
controlling for age, gender, and race. Thus, for these 
analyses as well, we have chosen to present only the 
bivariate analyses. 
Table 1.  Comparison of Baseline Characteristics Between Epidural Strategies 
  
Continuous Variables  POD1 (N=55) 
Mean (SD) 
POD2 (N=34) 
Mean (SD) 
All Subjects (N=89) 
Mean (SD) 
Age  68.6 (9.8)  66.5 (9.2)  67.8 (9.6) 
BMI  30.7 (7.2)  32.5 (6.7)  31.4 (7.0) 
Categorical Variables  POD1 (N=55) 
N (%) 
POD2 (N=34) 
N (%) 
All Subjects (N=89) 
N (%) 
Gender 
Female 
Male 
  
44 (80.0%) 
11 (20.0%) 
  
25 (73.5%) 
9 (26.5%) 
  
69 (77.5%) 
20 (22.5%) 
Race 
Caucasian 
Non-Caucasian 
  
46 (83.6%) 
9 (16.4%) 
  
29 (85.3%) 
5 (14.7%) 
  
75 (84.3%) 
14 (15.7%) 
Side of the operation 
Right 
Left 
  
34 (61.8%) 
21 (38.2%) 
  
21 (61.8%) 
13 (38.2%) 
  
55 (61.8%) 
34 (38.2%) 
Preoperative Ambulation 
Independent 
Ambulate with walking aid 
  
33 (60.0%) 
22 (40.0%) 
  
24 (70.6%) 
10 (29.4%) 
  
57 (64.0%) 
32 (36.0%) 
Charlson Comorbidity Index 
0-1 
 2 
  
39 (70.9%) 
16 (29.1%) 
  
24 (70.6%) 
10 (29.4%) 
  
63 (70.8%) 
26 (29.2%) 
Preoperative Living Status 
Alone 
Not alone 
  
14 (25.5%) 
41 (74.6%) 
  
11 (32.4%) 
23 (67.6%) 
  
25 (28.1%) 
64 (71.9%) 
Preoperative Diagnosis 
Osteoarthritis 
Other 
  
52 (94.5%) 
3 (5.5%) 
  
33 (97.1%) 
1 (2.9%) 
  
85 (95.5%) 
4 (4.5%) 
Smoking Status 
Current 
Past 
Never 
  
5 (9.6%) 
14 (26.9%) 
33 (63.5%) 
  
0 (0.0%) 
18 (54.5%) 
15 (45.5%) 
  
5 (5.9%) 
32 (37.6%) 
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Multivariable Analyses 
Length of Stay 
  Results of the robust regression with fixed bootstrap 
resampling found that the effect of epidural removal strategy 
on LOS depended on the subject’s discharge destination. 
LOS was not affected by epidural strategy when the subject 
was discharged to a rehabilitation facility. The mean LOS for 
these patients was 3.5 (95% CI: 3.3, 3.8) in the POD2-group 
and 3.2 (95% CI: 3.0, 3.4) in the POD1-group. However, 
LOS was affected by epidural strategy when the subject was 
discharged to their home. The mean LOS for these patients 
was 4.5 (95% CI: 4.2, 4.9) for the POD2-group and 3.3 (95% 
CI: 3.1, 3.6) for the POD1-group (Fig. 2). We did not find an 
association between the insurance status of the patient and 
LOS in this analysis. 
Supplementary Narcotic Medication Usage 
  We compared the amount of supplementary narcotic 
usage between the two groups on the day the epidural 
catheter was removed as well as the amount used on the 
following day. Thirty-five percent of patients in the POD1-
group and 59% of patients in the POD2-group were on PCAs 
on the first day the epidural catheters were removed (Fig. 1). 
Results of the repeated measures analysis did not find a 
significant interaction between time since the epidural 
catheter was removed and the epidural strategy on narcotic 
usage (p = 0.249), controlling for whether or not the patient 
used PCA. On the day the catheter was removed the POD1-
group used 108 mg of oxycodone-equivalents, while the 
POD2-group used 81 mg of oxycodone-equivalents. On the 
following day, the POD1-group had used 165 mg, while the 
POD2-group had used 121 mg. These differences between 
the groups were not statistically significant since the 95% 
confidence intervals overlap (Fig. 1). 
DISCUSSION 
  Total knee arthroplasty is a frequently performed 
procedure that predictably relieves pain and restores 
functional status, but involves a painful postoperative course. 
Many studies have compared the outcomes of epidural pain 
management to either general anesthesia with parenteral 
analgesia or to peripheral block methods [3, 4, 6-10, 24]. 
However, we are unaware of any studies comparing the 
effect of duration of epidural analgesia on in-hospital 
rehabilitation and utilization outcomes following TKA. This 
study took advantage of a change in practice policy from 
removal of the epidural catheter on the second postoperative 
day to removal on the first postoperative day. We performed 
a retrospective cohort study to compare the postoperative 
outcomes between patients with epidural catheters removed 
either on POD1 or on POD2. 
  Baseline characteristics between groups were quite 
similar, supporting the validity of comparing these two 
groups. The POD1-group had a median LOS of three days, 
while the POD2-group had a median LOS of four days. We 
found that this effect of epidural strategy on LOS was 
modified by discharge destination. Subjects that were 
discharged to home had a shorter LOS in the POD1-group 
than those in the POD2-group. Length of stay was similar 
between the two epidural strategies for participants 
discharged to a rehabilitation facility. While there was no 
significant difference in the percent of patients discharged to 
a rehabilitation facility between the epidural strategy groups, 
both POD1- and POD2-groups had higher rates of discharge 
to rehabilitation facilities than the national average. 
  
Table 2.  Comparison of Outcomes between Epidural Strategies 
  
POD1-Group POD2-Group 
Continuous Outcome 
Median  Mean  95% CI  Median  Mean  95% CI 
p-Value 
Length of stay (in days)*   3  3.2  (3.1, 3.4)  4  4.0  (3.7, 4.4)  <0.001 
Pain scores at post-op day 2 (0-10, 10 worse)†  7  6.4  (5.6, 7.2)  7  6.8  (6.0, 7.6)  0.445 
Continuous passive motion (in degrees) at post-op day 2†  55  49.6  (40.4, 58.8)  70  64.9  (55.3, 74.6)  0.031 
Distance walked (in feet) on post-op day 2†  10  37.9  (24.3, 51.5)  3  9.3  (2.5, 16.1)  < 0.001 
Passive flexion (in degrees) at POD1†  68  66.0   (61.6, 70.4)  80  73.4   (67.3, 79.5)  0.045 
Passive flexion (in degrees) at discharge†  80  75.9   (71.3, 80.5)  88  81.9   (77.0, 86.9)  0.078 
Change in passive flexion (degrees)† ‡  11.5  11.1   (6.1, 16.1)  6  9.2   (1.3, 17.0)  0.665 
Passive extension (degrees lacking full extension) at POD1†  10  9.5   (7.3, 11.7)  5  5.5   (3.7, 7.4)  0.013 
Passive extension (degrees lacking full extension) at discharge†  5  7.1   (4.7, 9.4)  3.5  3.9   (2.2, 5.5)  0.047 
Change in passive extension (in degrees)†‡  2  2.7   (1.0, 4.3)  0  1.5   (-0.6, 3.5)  0.356 
Categorical Outcome  N  %   95% CI  N  %  95% CI  p-value 
Independent or minimally assisted walking at discharge§  42  76.4%   (65.1,  87.6) 24 72.7%    (57.5, 87.9)  0.703 
Discharged to rehab§  32  58.2%   (45.2,  71.2) 21 61.8%    (45.4, 78.1)  0.738 
95% CI in parentheses. 
*The Wilcoxon rank-sum test was used to make comparisons between groups. 
†Independent samples t-test was used to make comparisons between groups. 
‡Positive values represent an improvement in passive flexion or extension. 
§Chi-square test of independence was used to make comparisons between groups. 36    The Open Orthopaedics Journal, 2010, Volume 4  Corbett et al. 
     
 
Fig. (1). Comparison of supplementary narcotic medication usage following epidural catheter removal by group. Mean cumulative 
narcotic usage in milligrams of oxycodone-equivalents are represented by the bars with the error bars representing the lower and upper 
bounds of the 95% confidence interval. The gray bars represent the POD1-group, while the white bars represent the POD2-group. Day 1 
represents the first 24 hours since the epidural catheter was removed. Day 2 represents the second 24 hours since the epidural catheter was 
removed. 
 
Fig. (2). Title: Mean length of stay stratified by epidural removal strategy and discharge destination. Mean length of stay, stratified by 
epidural-removal strategy using the robust regression with the bootstrap (10,000 replicates), are represented by the bars. The gray bars 
represent the POD1-group, while the white bars represent the POD2-group. The error bars represent the lower and upper bounds of the 95% 
confidence interval.  
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  This study demonstrated that patients with an epidural 
removed on the first postoperative day were mobilized 
sooner and discharged after a shorter hospital stay than 
patients whose epidural catheters were removed on the 
second postoperative day. The POD1-group also walked a 
greater distance than the POD2-group on the second 
postoperative day. We did not observe a difference in 
reported pain or need for assistance for walking at discharge. 
Patients in the POD1-group had worse range of motion on 
the first postoperative day. Typically, the epidural catheter 
was removed in the early morning and the physical therapist 
measured ROM in the afternoon. By the time ROM was 
measured the POD1-group had lost several degrees of 
flexion and extension. This difference was maintained 
throughout the hospitalization, such that the POD1-group 
had somewhat worse ROM at discharge. Whether this 
difference is maintained or ultimately dissipates is an 
important question for future work. 
  We note several limitations. Neither physical therapists 
who assessed mobility, functional status and pain nor study 
participants were blinded to the epidural removal strategy. 
They were not, however, aware that this comparison was 
going to be conducted. Furthermore, the study did not utilize 
a random allocation of study participants to epidural removal 
strategies under consideration. The quasi experimental 
design did result in well-balanced groups, however. While 
we showed that Medicare insurance status did not affect 
LOS, a larger study could have examined the association 
between payer and LOS in greater detail. Data were 
collected as part of routine clinical care and not under a 
research protocol. One consequence is that outcome data 
were not available for three patients, introducing possible 
bias. It is conceivable that different times of year in which 
the two groups were admitted (POD2-group in winter, 
POD1-group in summer) were associated with distinctive 
outcomes. Data on problems in other joints were not 
available but would also have been helpful to include in the 
multivariate analysis. Incomplete data in the medical records, 
particularly the rehabilitation and pharmacy notes, and lack 
of preoperative range of motion also limited the information 
available for this study. 
CONCLUSION 
  Longer term follow-up, randomized design and a cost-
effectiveness analysis are needed to more rigorously evaluate 
the outcomes of these two analgesic strategies, and the 
relationship between program costs and quality of life 
benefits. The balance between a shorter hospital stay and 
earlier walking achievement with the POD1-strategy -- vs 
better ROM with the POD2-strategy-- should be considered 
when planning TKA pain management. 
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APPENDIX 
Analgesic Equivalents and Conversion Factor to 
Oxycodone-Equivalents 
  
Analgesic  
Equivalents 
Conversion  
Factor 
Drug  
Parenteral  
(mg) 
PO  
(mg)  Parenteral   PO 
Codeine [19, 21]
  NS 200 NA 0.1 
Hydrocodone [19, 21, 22]  NA  30  NA  0.67 
Hydromorphone [20-22]  1.5  7.5  13.33  2.67 
Meperidine [20]  75  NS  0.268  NS 
Morphine [20, 21]  30  10  2  0.67 
Oxycodone [20, 21]  NA  20  NA  NA 
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